News
BIONOTE will Launch Vcheck Canine NT-proBNP during April

 Vcheck Canine NT-proBNP is an in vitro diagnostic test kit for the quantitative measurement of NT-proBNP concentration in canine serum. This test kit precisely quantifies the degree of elevation in NT-proBNP levels in dogs.

 


 

 

The ability to distinguish cardiac from non-cardiac causes of respiratory signs is important for further decisions on diagnostics and therapy. NT-proBNP allows to distinguish cardiac from respiratory disease in dogs with dyspnea.

 

Also, this marker helps to detect dogs with Myxomatous Mitral Valve Degeneration (MMVD), which is the most common heart disease in dogs. In dogs with stable Congestive Heart Failure (CHF) due to MMVD, NT-proBNP is of value in monitoring the effectiveness of medical treatment for CHF.

 

In large breeds, Dilated Cardiomyopathy (DCM) is the most common cause of heart disease. Annual screening tests are recommended to determine if DCM is present even if dogs at elevated risk are apparently healthy. The measurement of NT-proBNP increases the diagnostic accuracy with Holter monitoring (91% accuracy).

 

Vcheck Canine NT-proBNP: The one-step test procedure is easy to follow and provides fast results within 15 minutes using serum samples from dogs.

 

If you are interested in Vcheck Canine NT-proBNP, please contact your local distributor or mail to [bionote@bionote.co.kr].